News
The following exerpts from Cancer in the News have been reproduced with the permission of Cancer Council and Media Monitors. Cancer in the News is an edited summary of news items in daily national and capital city newspapers. We have only included items which we believe may be of interest to melanoma providers. This section will be updated weekly.
ALS Drug Further Validated For Melanoma Treatment Benefit. June 16, 2010 Medical News Today --- Research by investigators at The Cancer Institute of New Jersey (CINJ) is showing new promise in the treatment of melanoma, the most serious of skin cancers. The findings, published in the May 27, 2010, online edition of the Journal of Investigative Dermatology.
BRAF inhibitor shows promising preclinical activity against melanoma. June 15, EureKa Alert --- Preclinical findings recently published in Cancer Research, a journal of the American Association for Cancer Research, showed RG7204 (PLX4032) inhibited proliferation of tumor cell lines that expressed V600E-BRAF, a mutation found in several human cancers, including melanoma. The compound also showed partial or complete tumor regression and improved survival in a dose-dependent manner in preclinical efficacy models in rodents, without associated toxicity.
